Sodium valproate inhibits production of TNF-α and IL-6 and activation of NF-κB

Sodium valproate (VPA) is frequently used to treat epilepsy and convulsive disorders. Several reports have indicated that anti-epileptic drugs (AED) affect the immune system, but the mechanism has not been clear. We examined whether the commonly used AEDs, diazepam (DZP), carbamazepine (CBZ), phenobarbital (PB), phenytoin (PHT), and VPA, can inhibit activation of the nuclear transcription factor kappa B (NF-kappaB), in human monocytic leukemia cells (THP-1) and in human glioma cells (A-172). NF-kappaB is essential to the expression of the kappa light chain of immunoglobulin and proinflammatory cytokines. Electrophoretic mobility shift assays (EMSA) of nuclear extracts demonstrated that VPA inhibits NF-kappaB activation induced by lipopolysaccharide (LPS), but the other AEDs do not. Western blot analysis revealed that this inhibition is not linked to preservation of expression of IkappaBalpha protein. Chloramphenicol acetyltransferase (CAT) assay indicated that NF-kappaB-dependent reporter gene expression is suppressed in glioma cells pretreated with VPA. VPA significantly inhibited LPS-induced production of TNF-alpha and IL-6 by THP-1 cells, whereas other AEDs did not. The findings are consistent with the idea that VPA suppresses TNF-alpha and IL-6 production via inhibition of NF-kappaB activation. Our results suggest that VPA can modulate immune responses in vitro. These findings raise the possibility that such modulation might occur with clinical use of VPA.

[1]  S. Manna,et al.  α-Melanocyte-Stimulating Hormone Inhibits the Nuclear Transcription Factor NF-κB Activation Induced by Various Inflammatory Agents , 1998, The Journal of Immunology.

[2]  R. B. Chapin,et al.  Morphine Modulates NFκB Activation in Macrophages , 1998 .

[3]  E. Kansu,et al.  Serum immunoglobulins, complement levels and lymphocyte subpopulations in phenytoin-treated epileptic patients. , 1989, Immunopharmacology and immunotoxicology.

[4]  Y. Ben-Neriah,et al.  Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB , 1993, Nature.

[5]  J. Hiscott,et al.  Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.

[6]  E. Keller,et al.  Estrogen Inhibits Phorbol Ester-Induced IκBα Transcription and Protein Degradation , 1998 .

[7]  S. Gerstberger,et al.  Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation , 1995, Science.

[8]  S. Manna,et al.  IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. , 1998, Journal of immunology.

[9]  P. Baeuerle,et al.  Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.

[10]  P. Baeuerle,et al.  The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. , 1993, The Biochemical journal.

[11]  T. Libermann,et al.  Activation of interleukin-6 gene expression through the NF-kappa B transcription factor , 1990, Molecular and cellular biology.

[12]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.

[13]  B. Aggarwal,et al.  Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. M. Lipton,et al.  Systemically administered α-melanocyte-stimulating peptides inhibit NF-κB activation in experimental brain inflammation , 1999, Brain Research.

[15]  A. Malik,et al.  Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. , 1999, Molecular pharmacology.

[16]  M. Queiroz,et al.  Effects of sodium valproate on the immune response. , 1992, International journal of immunopharmacology.

[17]  David Baltimore,et al.  Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.

[18]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[19]  Aseem Kumar,et al.  Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. M. Potgieter,et al.  Epilepsy and IgA deficiency--the effect of sodium valproate. , 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[21]  R. Marienfeld,et al.  Cyclosporin A interferes with the inducible degradation of NF‐xB inhibitors, but not with the processing of p105/NF‐xB1 in T cells , 1997 .

[22]  P. Garzón,et al.  Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients. , 1985, General Pharmacology.

[23]  J. M. Lipton,et al.  α-Melanocyte-Stimulating Hormone Inhibits NF-κB Activation and IκBα Degradation in Human Glioma Cells and in Experimental Brain Inflammation , 1999, Experimental Neurology.

[24]  R. Pacifici,et al.  Cytokine Production in Blood Mononuclear Cells from Epileptic Patients , 1995, Epilepsia.

[25]  Eustice Dc,et al.  A sensitive method for the detection of beta-galactosidase in transfected mammalian cells. , 1991 .

[26]  K. Sugamura,et al.  Interleukin‐4 inhibits χ light chain expression and NFχB activation but not IχBα degradation in 70Z/3 murine pre‐B cells , 1995, European journal of immunology.

[27]  C. Franceschi,et al.  IMMUNOSUPPRESSION BY PHENYTOIN , 1976, The Lancet.

[28]  A. Lentsch,et al.  In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. , 1997, The Journal of clinical investigation.

[29]  L. O’Neill,et al.  Studies into the Effect of the Tyrosine Kinase Inhibitor Herbimycin A on NF-κB Activation in T Lymphocytes EVIDENCE FOR COVALENT MODIFICATION OF THE p50 SUBUNIT (*) , 1995, The Journal of Biological Chemistry.

[30]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[31]  P. Andersen,et al.  Immunoglobulin levels and autoantibodies in epileptics on long-term anticonvulsant therapy. , 2009, Acta medica Scandinavica.

[32]  M. F. Shannon,et al.  Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. , 1994, Journal of immunology.

[33]  S. Akira,et al.  Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Gaynor,et al.  Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR. , 1993, Virology.

[35]  R. Thieringer,et al.  CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity. , 1994, The Journal of biological chemistry.

[36]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[37]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.